D. Rajotte et al., CONTRIBUTION OF BOTH STAT AND SRF TCF TO C-FOS PROMOTER ACTIVATION BYGRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR/, Blood, 88(8), 1996, pp. 2906-2916
Granulocyte-macrophage colony-stimulating factor (GMCSF) is a hematopo
ietic growth factor that has been shown to support cell proliferation
in murine fibroblasts engineered to stably express both chains of the
human GM-CSF receptor (NIH-GMR). Because the proto-oncogene c-fos is b
elieved to provide a link between short-term signals elicited at the m
embrane and long-term cellular response, we chose to study the mechani
sm of GM-CSF-dependent cell regulation using c-fos promoter activity a
s a molecular marker in both NIH-GMR transfectants and in the CD34(+)
cell line TF-1. The importance of c-fos and related AP-1 activity in G
M-CSF signalling was suggested by a tight correlation between GMCSF-de
pendent activation of the c-fos promoter and cell proliferation and by
the inhibitory effect of a trans-dominant c-fos mutant on cell growth
. To evaluate the contribution of the serum response factor (SRF) asso
ciated with the ternary complex factor (TCF) and of STAT proteins to c
-fos promoter activation in response to GM-CSF, the SRF binding site (
SRE) and/or the STAT binding site (SIE) were inactivated. In serum-fre
e medium, both SRE and SIE are essential to c-fos promoter activation
by GM-CSF in NIH-GMR transfectants and in TF-1 cells. No response to G
M-CSF was observed when both sites were mutated. The nature of the STA
T family member was further investigated by Western blots and DNA reta
rdation assays using an SIE probe. Our data indicate that GM-CSF induc
ed DNA binding of both STAT1 and STAT3 in NIH-GMR and mainly of STAT3
in TF-1 cells. STAT5 tyrosine phosphorylation was also observed in TF-
1 cells. Finally, expression of a dominant negative MAPK mutant, ERK19
2A, resulted in a decrease of both SRE- and SIE-dependent activation o
f c-fos promoter by GM-CSF, suggesting that STAT1/3 are regulated not
only by tyrosine kinases, but also partially by MAPK. (C) 1996 by The
American Society of Hematology.